Found 6 matching trials
The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population
NAThe main goal of this study is to characterize whether the results of the O...
Location
Sunnybrook Health Sciences Centre
(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer
N/AThis study is a multi-center BCCA study that evaluates the impact of the On...
Location
BC Cancer Agency - Vancouver Centre
Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study
N/AThe study aims to evaluate the distribution of the Oncotype DX RS® genomic ...
Location
IRCCS Ospedale San Raffaele
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
PHASE2Multiple neoadjuvant endocrine trials demonstrate that women with good prog...
Location
Washington University School of Medicine
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
PHASE2This study aims to utilize a novel biomarker-driven approach to guide neoad...
Location
Washington University School of Medicine
Impact of Oncotype DX® on Treatment Recommendation and Its Economic Evaluation Under the Brazilian Society Perspective
N/A155 Pérola Byington Hospital patients presenting early stage luminal BC wer...